In this studio-based webinar, a multidisciplinary expert panel will address the new treatment landscape of metastatic UCa via interactive case discussions on managing AEs and the role of molecular testing.



Expert Panel

Philippe Barthélémy, Medical Oncology, Strasbourg Cancer Institute, Strasbourg, France

Viktor Grünwald, Medical Oncology, University Hospital Essen, Essen, Germany

Sylvie Rottey, Medical Oncology, Ghent University Hospital, Ghent, Belgium

Emmanuel Seront, Medical Oncology, Saint-Luc University Hospital, Brussels, Belgium

Bernadett Szabados, Urology, University College London Hospital & Barts Cancer Institute, London, UK



Learning objectives

Translate the newest clinical trial data for metastatic UCa to clinical practice.

Recognise AEs of novel therapies and use approaches for their appropriate management.

Assess the relevance of molecular tumour testing to guide the management of metastatic UCa.



This live event is EACCME-accredited. The webinar will also be available on demand but not accredited.



Organised by ISSECAM

In collaboration with OncoAlert

Supported by an independent educational grant from Johnson & Johnson and Merck KGaA